Skip to content

APOTEEK ROGGEN

Active
Private limited companyfounded 1986active for 40 yearsBrusselstraat 322, 1702 Dilbeek, BelgiumKBO/BCE: BE 0429.614.285
Summary

APOTEEK ROGGEN has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €572,143 and a net result of €9,128. Equity has been growing by about 11% per year since 2018. Its solvency ranks better than 68% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-10-1986 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.034.694.566 1702 Dilbeek, since 13-11-1986
Financial year end
31 December
Peppol
Reachable since 12-12-2025

Board and ownership

Board
  • Vande Maele GrietDirector · since 26-06-2013
  • BARCASDirector · since 25-06-2021 · permanent representative De Vlamynck Bart
  • De Vlamynck BartDirector · since 25-06-2021
Shareholders
  • BARCAS· score 942025 annual accounts of BARCAS

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€71,877
▼ 62.9%
Turnover
≈ €350,000
estimated
Profit
€9,128
▼ 87.5%
Equity
€572,143
▼ 5.1%
Total assets
€1.0m
▲ 25.6%
Staff
0.8 FTE
▼ 20.0%
  • 2025 accounts filed 24 days after the deadline
Filed on 24-08-2026
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 3.52, cash €338,574Size: total assets €1.0mFounded in 1986Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 59% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 80-17
equity 54.7% of total assets
Liquidity 82+7
short-term debt 23.9% · cash 32.4%
Profitability 70-10
return on assets 0.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.52 (3.34 in 2024), above the usual 1.5. Short-term debt is 23.9% and cash 32.4% of total assets. 45.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 68% of them on solvency, 85% on liquidity, 51% on profitability and 31% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 3.52, cash €338,574
NBB · annual accounts
lowers risk · Size: total assets €1.0m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Founded in 1986
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
24 days late
2024
24 days late
2023
11 days late
2022
30 days late
2021
26 days late
2020
29 days late
2019
29 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2025from €73,276 to €9,128 ▼ 87.5% View
  • Positive: 8 profitable years in a rowprofit 2025: €9,128 8 years View

Recent changes

  1. · Gazette deed Reappointments: BARCAS, De Vlamynck Bart and Vande Maele GrietPermanent representative: De Vlamynck Bart
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as APOTEEK ROGGEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €831,000 and €1.3m, founded between 1979 and 1990.

CompanyTotal assetsGross margin
APOTEEK ROGGEN Dilbeek€1.0m€0.07m
APOTHEEK STICKER Ieper€0.9m€0.08m
APOTHEEK JANS Riemst€1.2m€0.08m
APOTHEEK HOUBEN- HERMANS Sint-Truiden€1.0m€0.09m
DALEMANS Buggenhout€1.2m€0.06m
PHARMACIE GHEYSENS Mouscron€0.8m€0.08m
APOTEEK ENGSBERGEN Tessenderlo-Ham€1.3m€0.07m
Full comparison

Key facts about APOTEEK ROGGEN

What is the company number of APOTEEK ROGGEN?
The company number of APOTEEK ROGGEN is 0429.614.285. The VAT number is the same number with BE in front: BE 0429.614.285.
Where is APOTEEK ROGGEN based?
The registered office is at Brusselstraat 322, 1702 Dilbeek.Company details
What does APOTEEK ROGGEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTEEK ROGGEN?
The legal form of APOTEEK ROGGEN is Private limited company (BV).
When was APOTEEK ROGGEN founded?
APOTEEK ROGGEN was founded on 20-10-1986.
Is APOTEEK ROGGEN still active?
Yes, APOTEEK ROGGEN is an active enterprise in the KBO register.
How many employees does APOTEEK ROGGEN have?
APOTEEK ROGGEN had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTEEK ROGGEN?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €71,877 and 73 comparable companies (NACE 477). It probably lies between €170,000 and €510,000.
Is APOTEEK ROGGEN profitable?
In financial year 2025, APOTEEK ROGGEN made a profit of €9,128.
Where can I find the annual accounts of APOTEEK ROGGEN?
APOTEEK ROGGEN filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTEEK ROGGEN due?
APOTEEK ROGGEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.